Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens - PubMed (original) (raw)
Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens
N Kadowaki et al. J Exp Med. 2001.
Abstract
Toll-like receptors (TLRs) are ancient microbial pattern recognition receptors highly conserved from Drosophila to humans. To investigate if subsets of human dendritic cell precursors (pre-DC), including monocytes (pre-DC1), plasmacytoid DC precursors (pre-DC2), and CD11c(+) immature DCs (imDCs) are developed to recognize different microbes or microbial antigens, we studied their TLR expression and responses to microbial antigens. We demonstrate that whereas monocytes preferentially express TLR 1, 2, 4, 5, and 8, plasmacytoid pre-DC strongly express TLR 7 and 9. In accordance with these TLR expression profiles, monocytes respond to the known microbial ligands for TLR2 (peptidoglycan [PGN], lipoteichoic acid) and TLR4 (lipopolysaccharide), by producing tumor necrosis factor (TNF)-alpha and interleukin (IL)-6. In contrast, plasmacytoid pre-DCs only respond to the microbial TLR9-ligand, CpG-ODNs (oligodeoxynucleotides [ODNs] containing unmethylated CpG motifs), by producing IFN-alpha. CD11c(+) imDCs preferentially express TLR 1, 2, and 3 and respond to TLR 2-ligand PGN by producing large amounts of TNF-alpha, and to viral double-stranded RNA-like molecule poly I:C, by producing IFN-alpha and IL-12. The expression of distinct sets of TLRs and the corresponding difference in reactivity to microbial molecules among subsets of pre-DCs and imDCs support the concept that they have developed through distinct evolutionary pathways to recognize different microbial antigens.
Figures
Figure 2
Quantitation of TLR mRNA by real-time quantitative RT-PCR in freshly isolated monocytes (Mono), CD11c+ imDCs, and plasmacytoid pre-DCs (pDC), and in immature and mature DCs induced from them. Monocytes were cultured with 50 ng/ml GM-CSF and 200 U/ml IL-4 for 5 d to obtain imDC1 and were further stimulated with CD40L-transfected L cells for 24 h to obtain mDC1. CD11c+ imDCs were stimulated with CD40L-transfected L cells for 24 h to obtain mature CD11c+ DCs. Plasmacytoid pre-DCs were cultured with 10 ng/ml IL-3 for 5 d to obtain imDC2 and were further stimulated with CD40L-transfected L cells for 24 h to obtain mature DC2. The amounts of mRNA were quantitated by real-time quantitative RT-PCR, and were shown by arbitrary unit relative to the amount of ubiquitin mRNA. The data shown are representative of three experiments.
Figure 1
Detection of TLR mRNA by RT-PCR in freshly isolated monocytes, CD11c+ imDCs, and plasmacytoid pre-DCs. The three cell populations were isolated by cell sorting to the purity of >99%. cDNAs were amplified for 35 cycles and were separated on a 3% agarose gel containing ethidium bromide. The data shown are representative of three experiments.
Figure 3
TNF-α, IL-6, IFN-α, and IL-12 production by monocytes (Mono), CD11c+ imDCs, and plasmacytoid pre-DCs (pDC) stimulated with microbial molecules that trigger different TLR signaling. The three cell populations were cultured with 10 μg/ml PGN, 10 μg/ml LTA, 10 μg/ml LPS, 50 μg/ml poly I:C, or with 5 μM CpG-ODN AAC-30 for 24 h, and the concentrations of cytokines in the supernatants were measured by ELISA. The data shown are representative of four or five experiments.
Similar articles
- Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
Loré K, Betts MR, Brenchley JM, Kuruppu J, Khojasteh S, Perfetto S, Roederer M, Seder RA, Koup RA. Loré K, et al. J Immunol. 2003 Oct 15;171(8):4320-8. doi: 10.4049/jimmunol.171.8.4320. J Immunol. 2003. PMID: 14530357 - Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
Schmitt A, Li L, Giannopoulos K, Greiner J, Reinhardt P, Wiesneth M, Schmitt M. Schmitt A, et al. Transfusion. 2008 May;48(5):861-70. doi: 10.1111/j.1537-2995.2007.01616.x. Epub 2008 Jan 15. Transfusion. 2008. PMID: 18208411 - Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdörfer B, Giese T, Endres S, Hartmann G. Hornung V, et al. J Immunol. 2002 May 1;168(9):4531-7. doi: 10.4049/jimmunol.168.9.4531. J Immunol. 2002. PMID: 11970999 - Natural type I interferon-producing cells as a link between innate and adaptive immunity.
Kadowaki N, Liu YJ. Kadowaki N, et al. Hum Immunol. 2002 Dec;63(12):1126-32. doi: 10.1016/s0198-8859(02)00751-6. Hum Immunol. 2002. PMID: 12480256 Review. - Plasmacytoid dendritic cells: the key to CpG.
Rothenfusser S, Tuma E, Endres S, Hartmann G. Rothenfusser S, et al. Hum Immunol. 2002 Dec;63(12):1111-9. doi: 10.1016/s0198-8859(02)00749-8. Hum Immunol. 2002. PMID: 12480254 Review.
Cited by
- Cell damage shifts the microRNA content of small extracellular vesicles into a Toll-like receptor 7-activating cargo capable to propagate inflammation and immunity.
Salvi V, Gaudenzi C, Mariotti B, Giongrandi G, Alacqua S, Gianello V, Schioppa T, Tiberio L, Ceribelli A, Selmi C, Bergese P, Calza S, Del Prete A, Sozzani S, Bazzoni F, Bosisio D. Salvi V, et al. Cell Commun Signal. 2024 Nov 8;22(1):536. doi: 10.1186/s12964-024-01924-z. Cell Commun Signal. 2024. PMID: 39516877 Free PMC article. - MiR-5195-3p predicts clinical prognosis and represses colorectal cancer progression by targeting TLR4/MyD88 signaling.
Lv Y, Guo S, Jin L, Wang K, Li Y, Li H, Lu Y, Liu H. Lv Y, et al. Cell Div. 2024 Oct 10;19(1):29. doi: 10.1186/s13008-024-00133-x. Cell Div. 2024. PMID: 39390599 Free PMC article. - Effects of Synthetic Toll-Like Receptor 9 Ligand Molecules on Pulpal Immunomodulatory Response and Repair after Injuries.
Quispe-Salcedo A, Yamazaki T, Ohshima H. Quispe-Salcedo A, et al. Biomolecules. 2024 Aug 1;14(8):931. doi: 10.3390/biom14080931. Biomolecules. 2024. PMID: 39199319 Free PMC article. - TLR10 (CD290) Is a Regulator of Immune Responses in Human Plasmacytoid Dendritic Cells.
Deb P, Singh S, Kalyoussef E, Hess NJ, Tapping RI, Fitzgerald-Bocarsly P. Deb P, et al. J Immunol. 2024 Sep 1;213(5):577-587. doi: 10.4049/jimmunol.2200468. J Immunol. 2024. PMID: 38995177 - Plasmacytoid Dendritic Cells Mediate CpG-ODN-induced Increase in Survival in a Mouse Model of Lymphangioleiomyomatosis.
Amosu MM, Jankowski AM, McCright JC, Yang BE, Grano de Oro Fernandez J, Moore KA, Gadde HS, Donthi M, Kaluzienski ML, Maisel K. Amosu MM, et al. Am J Respir Cell Mol Biol. 2024 Nov;71(5):519-533. doi: 10.1165/rcmb.2023-0410OC. Am J Respir Cell Mol Biol. 2024. PMID: 38990702
References
- Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 1998;392:245–252. - PubMed
- Moser M., Murphy K.M. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 2000;1:199–205. - PubMed
- Kalinski P., Hilkens C.M., Wierenga E.A., Kapsenberg M.L. T-cell priming by type-1 and type-2 polarized dendritic cellsthe concept of a third signal. Immunol. Today. 1999;20:561–567. - PubMed
- Liu Y.J., Kadowaki N., Rissoan M.C., Soumelis V. T cell activation and polarization by DC1 and DC2. Curr. Top. Microbiol. Immunol. 2000;251:149–159. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials